Connection
Andrew Lapato to Encephalomyelitis, Autoimmune, Experimental
This is a "connection" page, showing publications Andrew Lapato has written about Encephalomyelitis, Autoimmune, Experimental.
|
|
Connection Strength |
|
 |
|
 |
|
0.277 |
|
|
|
-
Zhang J, Benedek G, Bodhankar S, Lapato A, Vandenbark AA, Offner H. IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient mice. J Neuroimmunol. 2015 Aug 15; 285:129-36.
Score: 0.121
-
Zhang J, Lapato A, Bodhankar S, Vandenbark AA, Offner H. Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice. Metab Brain Dis. 2015 Oct; 30(5):1117-27.
Score: 0.119
-
Karim H, Kim SH, Lapato AS, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK. Increase in chemokine CXCL1 by ER? ligand treatment is a key mediator in promoting axon myelination. Proc Natl Acad Sci U S A. 2018 06 12; 115(24):6291-6296.
Score: 0.037